Biomechanics Based Prediction of Preterm Delivery (Softcervix)

December 8, 2022 updated by: David Scheiner
Quantitative information on the biomechanical properties of the ecto-cervix in mid-pregnancy will be compared between women with term vs. preterm delivery. We aim to demonstrate that biomechanical data (ASP and CCI) might complement morphological data (CL) to improve prediction of preterm delivery. It is expected that women with preterm delivery will show stronger weakening of cervical tissue. Aspiration (ASP) and cervical CCI (cervical consistency index) measurements are performed at mid-pregnancy: detection at this time point is useful for therapy and biomechanical modifications are already significant so to enable differentiation by biomechanical measurements (ASP and CCI).

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

1002

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Leuven, Belgium, 3000
        • University Hospital of Leuven
      • Aarau, Switzerland
        • Kantonsspital Aarau, Frauenklinik
      • Baden, Switzerland
        • Kantonsspital Baden, Frauenklinik
      • Basel, Switzerland
        • Universitatsspital Basel, Frauenklinik
      • Frauenfeld, Switzerland
        • Kantonsspital Frauenfeld, Frauenklinik
      • Genève, Switzerland
        • Hopitaux Universitaires de Geneve (HUG)
      • Luzern, Switzerland
        • Kantonsspital Luzern, Frauenklinik
      • Münsterlingen, Switzerland
        • Kantonsspital Münsterlingen
      • St. Gallen, Switzerland
        • Kantonsspital St. Gallen, Klinik für Gynäkologie und Geburtshilfe
      • Winterthur, Switzerland
        • Kantonsspital Winterthur
      • Zollikon, Switzerland
        • Praxis Zollikon
      • Zurich, Switzerland, 8091
        • University Hospital of Zurich, Dept. OB/Gyn
      • Zurich, Switzerland
        • Stadtspital Triemli, Frauenklinik

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

All pregnant women at our institutions between 18+0/7 and 22+0/7 weeks of pregnancy and postpartum

Description

Inclusion Criteria:

  • All pregnant women presenting at their mid pregnancy consultation (18+0 - 22+0 weeks of pregnancy) are eligible
  • Signed informed consent after being informed is a prerequisite for enrollment.

Exclusion Criteria:

  • Communication problems
  • Missing consent
  • Age<18
  • Active bleeding / Premature Rupture of Membranes (PROM)
  • Active genital infection
  • Known carrier of HIV or Hepatitis B or C
  • Placenta praevia
  • Müllerian anomalies
  • known or suspected non-compliance, drug or alcohol abuse
  • cerclage
  • use of pessary

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Pregnancy
No intervention is done except for measuring the stiffness of the cervix in pregnant women

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Difference in cervical stiffness in women with/without preterm delivery
Time Frame: Measurements between 18+0/7 and 22+0/7 weeks of pregnancy and postpartum
The biomechanical measurements and morphological data obtained at mid-pregnancy are compared between women with/without preterm delivery and are expected to significantly differ. The diagnostic power for preterm delivery of aspiration, CCI and the other factors will be determined.
Measurements between 18+0/7 and 22+0/7 weeks of pregnancy and postpartum

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: David A Scheiner, MD, University of Zurich

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2014

Primary Completion (Actual)

December 8, 2022

Study Completion (Actual)

December 8, 2022

Study Registration Dates

First Submitted

January 13, 2014

First Submitted That Met QC Criteria

January 14, 2014

First Posted (Estimate)

January 15, 2014

Study Record Updates

Last Update Posted (Estimate)

December 9, 2022

Last Update Submitted That Met QC Criteria

December 8, 2022

Last Verified

December 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • KEK-ZH 2013-0244
  • 2013-MD-0036 (Other Identifier: Swissmedic)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Preterm Delivery

Clinical Trials on Pregnolia System

Subscribe